NCT06629636View on ClinicalTrials.gov

Investigate the Efficacy of Using NMN to Improve Embryo Development Capacity.

NARecruitingINTERVENTIONAL

Enrollment

60

Participants

Timeline

Start Date

August 20, 2024

Primary Completion Date

September 30, 2025

Study Completion Date

December 31, 2026

Conditions

Repeated IVF FailureFemale Infertility

Interventions

DIETARY_SUPPLEMENT

NMN capsule

Total of 900mg/day for 8 weeks

OTHER

Placebo

NMN-free placebo capsules for 8 weeks

Trial Locations (1)

5500015

RECRUITING

IVF Namba Clinic, Sankaky Medical Corporation, Osaka

Sponsors

Collaborators (1)

Abinopharm, Inc

All Listed Sponsors

collaborator

Abinopharm, Inc

NETWORK

collaborator

Aba Chemicals Co Ltd

UNKNOWN

lead

Sunkaky Medical Cooperation

INDUSTRY

NCT06629636 - Investigate the Efficacy of Using NMN to Improve Embryo Development Capacity. | Biotech Hunter | Biotech Hunter